Literature DB >> 21951513

Predictors of recurrence of prolapse after procedure for prolapse and haemorrhoids.

S Festen1, H Molthof, A A W van Geloven, S Luchters, M F Gerhards.   

Abstract

AIM: The procedure for prolapse and haemorrhoids (PPH) is an effective surgical therapy for symptomatic haemorrhoids. Compared with haemorrhoidectomy, meta-analysis has shown PPH to be less painful, with higher patient satisfaction and a quicker return to work, but at the cost of higher prolapse recurrence rates. This is the first report describing predictors of prolapse recurrence after PPH.
METHOD: A cohort of patients with symptomatic haemorrhoids, treated with PPH in our hospital between 2002 and 2009, was retrospectively analysed. Multivariate analysis was performed to identify patient-related and perioperative predictors associated with persisting prolapse and prolapse recurrence.
RESULTS: In total, 159 consecutively enrolled patients were analysed. Persistence and recurrence of prolapse was observed in 16% of the patients. Increased surgical experience showed a trend towards lower recurrence rates. Multivariate analysis identified female gender, long duration of PPH surgery and the absence of muscle tissue in the resected specimen as independent predictors of postoperative persistence of prolapse of haemorrhoids. The absence of prior treatment with rubber band ligation (RBL) as well as increased PPH experience at the hospital showed a trend towards a higher rate of prolapse recurrence.
CONCLUSION: In order to reduce recurrence of prolapse, PPH should be performed by a surgeon with adequate PPH experience, patients should be treated with RBL prior to PPH and a resection of mucosa with underlying muscle fibres should be strived for.
© 2011 The Authors. Colorectal Disease © 2011 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Mesh:

Year:  2012        PMID: 21951513     DOI: 10.1111/j.1463-1318.2011.02837.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  7 in total

1.  Tailored prolapse surgery for the treatment of haemorrhoids and obstructed defecation syndrome with a new dedicated device: TST STARR Plus.

Authors:  Gabriele Naldini; Jacopo Martellucci; Roberto Rea; Stefano Lucchini; Michele Schiano di Visconte; Angelo Caviglia; Claudia Menconi; Donglin Ren; Ping He; Domenico Mascagni
Journal:  Int J Colorectal Dis       Date:  2014-02-26       Impact factor: 2.571

2.  Tailored prolapse surgery for the treatment of hemorrhoids with a new dedicated device: TST Starr plus.

Authors:  G Naldini; B Fabiani; C Menconi; I Giani; G Toniolo; J Martellucci
Journal:  Int J Colorectal Dis       Date:  2015-07-25       Impact factor: 2.571

3.  Long-term results after stapled hemorrhoidopexy: a survey study with mean follow-up of 12 years.

Authors:  A Sturiale; B Fabiani; C Menconi; D Cafaro; F Fusco; G Bellio; M Schiano di Visconte; G Naldini
Journal:  Tech Coloproctol       Date:  2018-10-04       Impact factor: 3.781

4.  Clinical efficacy of integral theory-guided laparoscopic integral pelvic floor/ligament repair in the treatment of internal rectal prolapse in females.

Authors:  Yang Yang; Yong-Li Cao; Yuan-Yao Zhang; Shou-Sen Shi; Wei-Wei Yang; Nan Zhao; Bing-Bing Lyu; Wen-Li Zhang; Dong Wei
Journal:  World J Clin Cases       Date:  2020-12-06       Impact factor: 1.337

5.  Outcomes of Modified Tissue Selection Therapy Stapler in the Treatment of Prolapsing Hemorrhoids.

Authors:  Chenchen Yuan; Chongjun Zhou; Rong Xue; Xiaofeng Jin; Chun Jin; Chenguo Zheng
Journal:  Front Surg       Date:  2022-03-03

6.  Indications, Feasibility, and Safety of TST STARR Plus Stapler for Degree III Hemorrhoids: A Retrospective Study of 125 Hemorrhoids Patients.

Authors:  Jun Wei; Xufeng Ding; Jie Jiang; Lijiang Ji; Hua Huang
Journal:  Front Surg       Date:  2022-04-13

7.  Tissue selecting technique mega-window stapler combined with anal canal epithelial preservation operation for the treatment of severe prolapsed hemorrhoids: A study protocol for a randomized controlled trial.

Authors:  Lijiang Ji; Lei Li; Liping Weng; Yuemeng Hu; Hua Huang; Jun Wei
Journal:  Medicine (Baltimore)       Date:  2020-11-06       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.